Search

everythinglearnresearchcommunity

for

Search:↓

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Higher antigliadin antibody levels are linked to alopecia areata severity.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Most patients improved with oral contraceptives, but some needed additional treatment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New treatments for hair loss may target specific pathways and generate new hair follicles.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

TNF-alpha inhibitors can cause various immune-related skin issues.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Platelet-rich plasma can potentially promote hair growth by stimulating cell growth and increasing certain proteins.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Stem cell therapy may help treat tough hair loss cases.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Using neurohormones to control keratin can lead to new skin disease treatments.